At Biortus, we utilize three widely used expression host systems, bacteria, insect cells, and mammalian cells, for recombinant protein expression. We continue to develop new techniques, such as new affinity tags, new expression systems and membrane protein purification methods for a better protein production.
Our cryo-EM team has a combined experience of over 35 years and published many cryo-EM related research in high-impact journals. Syncretizing our cryo-EM expertise with access to high-end cryo-EM equipment, Biortus is aspired to becoming the pioneering CROs in providing high resolution cryo-EM structures for our clients.
Biortus provides X-ray based high resolution crystal structures for epitope mapping, protein engineering, and structure-based or fragment-based drug discovery. With the in-house instruments and access to synchrotron data collection facilities worldwide, we can provide fast turnaround and high-throughput crystal screening and high-resolution data collection.
Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.